Search Within

Jamie Erin Chaft

Formats
  1. Meeting Abstract (147)
  2. Journal Article (130)
  3. Review (9)
  4. Editorial (2)
  5. Miscellaneous (2)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (293)
  2. Solid Tumor Oncology Division (293)
  3. Thoracic Oncology (293)
  4. Surgery (114)
  5. Department of Pathology and Laboratory Medicine (98)
  6. GSK Faculty (76)

More Groups

People
  1. Mark Kris (107)
  2. Matthew Hellmann (68)
  3. Andreas Rimner (59)
  4. David Jones (50)
  5. Abraham Wu (47)
  6. Valerie Rusch (47)

More People

Years
  1. 2025 (9)
  2. 2024 (29)
  3. 2023 (28)
  4. 2022 (23)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Thoracic Oncology (60)
  2. Journal of Clinical Oncology (58)
  3. International Journal of Radiation Oncology, Biology, Physics (25)
  4. Annals of Oncology (13)
  5. Journal of Thoracic and Cardiovascular Surgery (10)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. American Society of Clinical Oncology (62)
  3. American Association for Cancer Research (23)
  4. Oxford University Press (16)
  5. Nature Publishing Group (12)
  6. Mosby Elsevier (10)

More Publishers

Results (293)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)
    Meeting Abstract

    Garassino, M. C.; Wakelee, H. A.; Spicer, J.; Liberman, M.; Kato, T.; Tsuboi, M.; Lee, S. H.; Chen, K. N.; Dooms, C. A.; Majem, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Outcomes with perioperative durvalumab (D) in pts with resectable NSCLC and baseline N2 lymph node involvement (N2 R-NSCLC): An exploratory subgroup analysis of AEGEAN
    Meeting Abstract

    Heymach, J.; Reck, M.; Mitsudomi, T.; Taube, J. M.; Spira, A. I.; Chaft, J. E.; Doherty, G. J.; Mann, H.; Fouad, T. M.; Harpole, D. H.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Molecular characterization of NUT carcinoma: A report from the NUT carcinoma registry
    Meeting Abstract

    Luo, J.; Kim, J. J.; Walton, S. A.; Nguyen, T.; Paik, P. K.; Chaft, J. E.; Hsu, R.; Piha-Paul, S. A.; Janne, P. A.; Sholl, L. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • The phase 3 INTerpath-002 study design: Individualized neoantigen therapy (INT) V940 (mRNA-4157) plus pembrolizumab vs placebo plus pembrolizumab for resected early-stage non-small-cell lung cancer (NSCLC)
    Meeting Abstract

    Lee, J. M.; Spicer, J.; Nair, S.; Khattak, A.; Brown, M.; Meehan, R. S.; Shariati, N. M.; Deng, X.; Samkari, A.; Chaft, J. E.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Multi-institution real world analysis of patients with non-small cell lung cancer (NSCLC) treated with standard of care (SOC) neoadjuvant chemo-immunotherapy (chemoIO)
    Meeting Abstract

    Cooper, A. J.; Gorria, T.; Conroy, M. R.; Ricciuti, B.; Pecci, F.; Aldea, M.; Anagnostou, V.; Shaverdian, N.; Bott, M.; Forde, P. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Preliminary results of the Lung Cancer Mutation Consortium LCMC4 evaluation of actionable drivers in early stage lung cancer (LEADER) screening trial
    Meeting Abstract

    Chaft, J. E.; Swanson, S.; Lee, J. M.; Lin, J.; Tsukada, H.; Li, T.; Ripley, R. T.; Kaifi, J. T.; Baik, C. S.; Bunn, P. A. Jr.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Can unresectable non-small cell lung cancer become resectable? [Interview]
    Miscellaneous

    Chaft, J. E.
    Clinical Advances in Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Lung resection after initial nonoperative treatment for non–small cell lung cancer
    Journal Article

    Dunne, E. G.; Fick, C. N.; Tan, K. S.; Toumbacaris, N.; Mastrogiacomo, B.; Adusumilli, P. S.; Rocco, G.; Molena, D.; Huang, J.; Park, B. J.; more...
    Journal of Thoracic and Cardiovascular Surgery (2024)

    Fulltext@MSK | Save
  • Induction therapy for non–small cell lung cancer
    Editorial

    Cooper, A.; Chaft, J. E.; Bott, M. J.
    Journal of Thoracic and Cardiovascular Surgery (2024)

    Fulltext@MSK | Save